Immunome Inc. (IMNM) stock
IMNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Mar 31, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$17.18−0.43 (-2.44%)
Close on Nov 17, 2026Market cap $1.95BP/E –Yield –
Immunome gross margin
Gross margin is gross profit as a percentage of revenue.
No gross margin figures for Immunome
Immunome has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?